Skip to content

MediDeferm

Active
Private limited companyfounded 20242 yrs activeWerchtersesteenweg 58, 3130 Begijnendijk, BelgiumKBO/BCE: BE 1012.361.086
Summary

MediDeferm has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €209,822 and a net result of €216,352. Its solvency ranks better than 62% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability100▲+100
Solvency100▲+100
Growth78
Track record82
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €20,000 at 30 days only on tighter terms
Liquidity ample (current ratio 3.88; short-term debt: 25.2% and cash: 78.4% of total assets), and 25.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
74.8%
Return on assets
77.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
59 d early
2024
70 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 65 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 9 August 2024, MediDeferm was incorporated as a Private limited company.1 Astrid Janssens has served as director of the company since 2026.2 The company has filed 2 sets of annual accounts, the latest for fiscal year 2025.3

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 15-07-2026
  3. 3National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€209,822
2024 · -€6,530
Total assets
€280,350▲ 6,928%
2024 · €3,989
Net result
€216,352
2024 · -€9,530
Working capital
€202,986
2024 · -€9,768
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20242025
Operating result-€9,329-€283,224
Net result-€9,530below the sector's middle half-€216,352above the sector's middle half
Equity-€6,530below the sector's middle half-€209,822within the sector's middle half
Total assets€3,989below the sector's middle half-€280,350within the sector's middle half▲ 6,928%
Debt€10,518-€70,528▲ 571%
Working capital-€9,768below the sector's middle half-€202,986within the sector's middle half
Solvency74.8%within the sector's middle half
Current ratio3.88within the sector's middle half
Return on assets (ROA)77.2%above the sector's middle half
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€100,000€0€100,000€200,000€300,000Operating result 2024: -€9,329-€9,329Net result 2024: -€9,530-€9,530Operating result 2025: €283,224€283,224Net result 2025: €216,352€216,35220242025-€100,000€0€100,000€200,000€300,000Operating result 2024: -€9,329-€9,330Net result 2024: -€9,530-€9,530Operating result 2025: €283,224€283,000Net result 2025: €216,352€216,00020242025
The operating result returns to profit in 2025: €283,224 after a loss of €9,329 in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €280,350
Fixed assets €6,836 ▲ 111%
Current assets €273,514 ▲ 36,321%
Equity and liabilities €280,350
Equity €209,822
Debt €70,528
Debt finances 25.2% of the balance-sheet total.
Key figures and ratios
2025 value · change against 2024
EBITDA
€284,576▲
2024 · -€9,072
Cash flow
€217,703▲
2024 · -€9,272
Debt to equity
0.34
ROE
103.1%
Interest coverage
4065.37▲
2024 · -57.69
Debt ≤ 1 year
€70,528▲
2024 · €10,518
Income taxes
€66,803▲
2024 · €43
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,276 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
2.2% stopped otherwise
96% still going

A further 0.5% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,276 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 37 lines
Balance sheet Code20242025
Assets
Total assets20/58€3,989€280,350▲
Fixed assets21/28€3,238€6,836▲
Tangible fixed assets22/27€3,238€6,836▲
Plant, machinery and equipment23€1,280€5,305▲
Furniture and vehicles24€1,958€1,531▼
Current assets29/58€751€273,514▲
Amounts receivable within one year40/41-€53,641
Other amounts receivable41-€53,641
Cash at bank and in hand54/58€751€219,873▲
Equity and liabilities
Total equity and liabilities10/49€3,989€280,350▲
Equity10/15-€6,530€209,822▲
Contributions10/11€3,000€3,000=
Reserves13-€206,822
Distributable reserves133-€206,822
Profit (loss) carried forward14-€9,530-
Amounts payable17/49€10,518€70,528▲
Amounts payable within one year42/48€10,518€70,528▲
Trade debts44€1,180€1,099▼
Suppliers440/4€1,180€1,099▼
Taxes, remuneration and social security45€776€69,429▲
Taxes450/3€43€69,429▲
Remuneration and social security454/9€733-
Other amounts payable47/48€8,563-
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€257€1,351▲
Other operating charges640/8-€254
Gross operating margin9900-€9,072€284,829▲
Operating profit (loss)9901-€9,329€283,224▲
Financial charges65/66B€157€70▼
Recurring financial charges65€157€70▼
Profit (loss) for the period before taxes9903-€9,486€283,154▲
Income taxes67/77€43€66,803▲
Profit (loss) for the period9904-€9,530€216,352▲
Profit (loss) for the period to be appropriated9905-€9,530€216,352▲
Appropriation of the result
Profit (loss) to be appropriated9906-€9,530€206,822▲
Profit (loss) brought forward from the previous period14P--€9,530
Transfer to equity691/2-€206,822
To other reserves6921-€206,822

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€257€1,351▲ 425%
Other operating charges640/8-€254-
Gross operating margin9900-€9,072€284,829▲ 3,240%
Operating profit (loss)9901-€9,329€283,224▲ 3,136%
Financial charges65/66B€157€70▼ 55.5%
Recurring financial charges65€157€70▼ 55.5%
Profit (loss) for the period before taxes9903-€9,486€283,154▲ 3,085%
Income taxes67/77€43€66,803▲ 154,321%
Profit (loss) for the period9904-€9,530€216,352▲ 2,370%
Profit (loss) for the period to be appropriated9905-€9,530€216,352▲ 2,370%
Line20242025Change
Assets
Total assets20/58€3,989€280,350▲ 6,928%
Fixed assets21/28€3,238€6,836▲ 111%
Tangible fixed assets22/27€3,238€6,836▲ 111%
Plant, machinery and equipment23€1,280€5,305▲ 315%
Furniture and vehicles24€1,958€1,531▼ 21.8%
Current assets29/58€751€273,514▲ 36,321%
Amounts receivable within one year40/41-€53,641-
Other amounts receivable41-€53,641-
Cash at bank and in hand54/58€751€219,873▲ 29,179%
Equity and liabilities
Total equity and liabilities10/49€3,989€280,350▲ 6,928%
Equity10/15-€6,530€209,822▲ 3,313%
Contributions10/11€3,000€3,000=
Reserves13-€206,822-
Distributable reserves133-€206,822-
Profit (loss) carried forward14-€9,530--
Amounts payable17/49€10,518€70,528▲ 571%
Amounts payable within one year42/48€10,518€70,528▲ 571%
Trade debts44€1,180€1,099▼ 6.8%
Suppliers440/4€1,180€1,099▼ 6.8%
Taxes, remuneration and social security45€776€69,429▲ 8,846%
Taxes450/3€43€69,429▲ 160,391%
Remuneration and social security454/9€733--
Other amounts payable47/48€8,563--
Line20242025Change
Profit (loss) for the period9904-€9,530€216,352▲ 2,370%
+ Depreciation and write-downs630€257€1,351▲ 425%
Operating cash flow (approximation)-€9,272€217,703▲ 2,448%
Investment in fixed assets (approximation)--€4,949-
Change in cash-€219,122-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
15-07
State Gazette act Appointment: Astrid Janssens (director)
2 facts ▸
  • General meeting, 01-07-2026
  • Director appointment, Astrid Janssens (director)
02-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Back to profitnet €216,352
Net result €216,352 after one loss-making year.
31-12
Financial Liquidity times 54current ratio 3.88
Current ratio from 0.07 to 3.88.
31-12
Financial Equity above €200,000Eq €209,822
Equity rises from -€6,530 to €209,822.
22-05
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 1 act read

Directors · office · real estate

Directors
1 director, no change since 2026
Astrid Janssens
Director · since 01-07-2026
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Begijnendijk · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
534 m²
Building footprint
155 m²
Volume, LiDAR
597 m³
Parcel 24010C0048/00S000, Flanders · tallest building 9.5 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
MediDeferm
Werchtersesteenweg 58, 3130 BegijnendijkSpecialist medical practice
since 20242.362.581.488
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24010C0048/00S000 Flanders 534 m² 1 · 155 m² 9.4 m · 1 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

1 person since 2026, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
Astrid Janssens
  • Director, from 01-07-2026 to date
See the board, name and seat on a given date →

Structure & network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Similar companies · same sector, comparable size

Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 6,666 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded09-08-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:1012361086
Also 9925:BE1012361086
Registered 12-07-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.